"ovarian tumorigenesis" trang 11 - tải miễn phí từ tailieuXANH
Investigating the performance and costeffectiveness of the simple ultrasound-based rules compared to the risk of malignancy index in the diagnosis of ovarian cancer (SUBSONiC-study): Protocol of a prospective multicenter cohort study in the Netherlands

Investigating the performance and costeffectiveness of the simple ultrasound-based rules compared to the risk of malignancy index in the diagnosis of ovarian cancer (SUBSONiC-study): Protocol of a prospective multicenter cohort study in the Netherlands
6    62    0
High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma

High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma
8    54    0
Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas

Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas
13    56    0
Tumor evolution and intratumor heterogeneity of an epithelial ovarian cancer investigated using next-generation sequencing

Tumor evolution and intratumor heterogeneity of an epithelial ovarian cancer investigated using next-generation sequencing
9    64    0
Fibulin-4 is associated with tumor progression and a poor prognosis in ovarian carcinomas

Fibulin-4 is associated with tumor progression and a poor prognosis in ovarian carcinomas
12    61    1
Prediction of resistance to chemotherapy in ovarian cancer: A systematic review

Prediction of resistance to chemotherapy in ovarian cancer: A systematic review
32    73    1
Retrospective analysis of the impact of platinum dose reduction and chemotherapy delays on the outcomes of stage III ovarian cancer patients

Retrospective analysis of the impact of platinum dose reduction and chemotherapy delays on the outcomes of stage III ovarian cancer patients
8    70    1
Low levels of IGFBP7 expression in high-grade serous ovarian carcinoma is associated with patient outcome

Low levels of IGFBP7 expression in high-grade serous ovarian carcinoma is associated with patient outcome
16    78    0
A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer

A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer
7    57    0
Chk1 Inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers

Chk1 Inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers
14    54    0
Polyploid giant cancer cells with budding and the expression of cyclin E, S-phase kinase-associated protein 2, stathmin associated with the grading and metastasis in serous ovarian tumor

Polyploid giant cancer cells with budding and the expression of cyclin E, S-phase kinase-associated protein 2, stathmin associated with the grading and metastasis in serous ovarian tumor
9    49    0
Role of malignant ascites on human mesothelial cells and their gene expression profiles

Role of malignant ascites on human mesothelial cells and their gene expression profiles
13    66    0
A role for PAX8 in the tumorigenic phenotype of ovarian cancer cells

A role for PAX8 in the tumorigenic phenotype of ovarian cancer cells
8    39    0
Genomic profile of ovarian carcinomas

Genomic profile of ovarian carcinomas
7    52    0
Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden

Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden
22    62    0
Glucocorticoid receptor repression mediated by BRCA1 inactivation in ovarian cancer

Glucocorticoid receptor repression mediated by BRCA1 inactivation in ovarian cancer
7    46    0
MUC16 mucin (CA125) attenuates TRAIL-induced apoptosis by decreasing TRAIL receptor R2 expression and increasing c-FLIP expression

MUC16 mucin (CA125) attenuates TRAIL-induced apoptosis by decreasing TRAIL receptor R2 expression and increasing c-FLIP expression
14    54    0
Bithionol inhibits ovarian cancer cell growth In Vitro - studies on mechanism(s) of action

Bithionol inhibits ovarian cancer cell growth In Vitro - studies on mechanism(s) of action
17    64    0
Cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum-sensitive epithelial ovarian cancer (SOCceR trial): A multicenter randomised controlled study

Cytoreductive surgery followed by chemotherapy versus chemotherapy alone for recurrent platinum-sensitive epithelial ovarian cancer (SOCceR trial): A multicenter randomised controlled study
7    70    0
An increased risk of epithelial ovarian cancer in Taiwanese women with a new surgico-pathological diagnosis of endometriosis

An increased risk of epithelial ovarian cancer in Taiwanese women with a new surgico-pathological diagnosis of endometriosis
10    65    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.